David-Alexandre C. Gros

David-Alexandre C. Gros

Chief Executive Officer at ELEDON PHARMACEUTICALS, INC.

Net worth: 16 200 $ as of 2024-02-28

51 year
Health Technology
Consumer Services
Commercial Services

Profile

Founder of Eliem Therapeutics, Inc. and Imbria Pharmaceuticals, Inc., David-Alexandre C.
Gros
presently holds the position of Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. In the past he was Chairman & Chief Executive Officer for Imbria Pharmaceuticals, Inc., President, Chief Operating & Financial Officer at Neurocrine Biosciences, Inc., Chief Financial Officer of Alnylam Pharmaceuticals, Inc., Chief Strategy Officer & Executive Vice President at Sanofi and Chief Strategy Officer for Sanofi SA (a subsidiary of Sanofi), Associate Principal at McKinsey & Co., Inc., Principal at Centerview Partners LLC and Director at Eliem Therapeutics, Inc. David-Alexandre C.
Gros
received an undergraduate degree from Dartmouth College, an MBA from Harvard Business School and a doctorate from The Johns Hopkins University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-30 9,000 ( 0.04% ) 16 200 $ 2024-02-28

David-Alexandre C. Gros active positions

CompaniesPositionStart
ELEDON PHARMACEUTICALS, INC. Chief Executive Officer 2020-09-08
All active positions of David-Alexandre C. Gros

Former positions of David-Alexandre C. Gros

CompaniesPositionEnd
NEUROCRINE BIOSCIENCES, INC. President 2017-12-30
ALNYLAM PHARMACEUTICALS, INC. Director of Finance/CFO 2017-01-05
SAINT JEAN GROUPE Director/Board Member 2015-12-30
SANOFI Corporate Officer/Principal 2015-05-31
Corporate Officer/Principal 2010-12-31
See the detail of David-Alexandre C. Gros's experience

Training of David-Alexandre C. Gros

Dartmouth College Undergraduate Degree
Harvard Business School Masters Business Admin
The Johns Hopkins University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David-Alexandre C. Gros's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
NEUROCRINE BIOSCIENCES, INC.

Health Technology

SANOFI

Health Technology

SAINT JEAN GROUPE

Consumer Non-Durables

ALNYLAM PHARMACEUTICALS, INC.

Health Technology

ELEDON PHARMACEUTICALS, INC.

Health Technology

ELIEM THERAPEUTICS, INC.

Health Technology

Private companies4

Commercial Services

Finance

Sanofi SA

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. David-Alexandre C. Gros